OBI — Ondine Biomedical Share News
0.000.00%
- £44.06m
- £41.37m
- CA$2.05m
RCS - Ondine Biomedical - Steriwave Up for 2025 “Product of the Year” Award
AnnouncementRCS - Ondine Biomedical - Expanding Steriwave Use Across Vancouver Island
AnnouncementRCS - Ondine Biomedical - Steriwave Expands into ENT Surgery in Spain
AnnouncementRCS - Ondine Biomedical - New Independent Study Supports Photodisinfection
AnnouncementRCS - Ondine Biomedical - Finalist for 2nd National Award for SSI reduction
AnnouncementREG - Ondine Biomedical - First German Hospital Pilots Steriwave
AnnouncementRCS - Ondine Biomedical - Ondine shortlisted for HSJ Partnership Award
AnnouncementREG - Ondine Biomedical - Topline Results Significant in Steriwave ICU Study
AnnouncementREG - Ondine Biomedical - Cambridge’s Papworth Hospital Pilots Steriwave
AnnouncementREG - Ondine Biomedical - Ondine Biomedical Continues Growth in H1 2025
AnnouncementRCS - Ondine Biomedical - Steriwave Now Protecting Patients with Cancer
AnnouncementREG - Ondine Biomedical - Notice of Interim Results & Investor Presentation
AnnouncementRCS - Ondine Biomedical - Ondine Presents Major Economic Benefits at ICPIC
AnnouncementRCS - Ondine Biomedical - Steriwave proven to be effective against C Auris
AnnouncementREG - Ondine Biomedical - Grant of Options
AnnouncementRCS - Ondine Biomedical - Steriwave Featured on CNBC’s Worldwide Exchange
AnnouncementREG - Ondine Biomedical - Notification of major holdings - hInsight
AnnouncementREG - Ondine Biomedical - Notification of major holdings - Carolyn Cross
AnnouncementREG - Ondine Biomedical - Notification of major holdings - Robert Cross
Announcement